Vanguard Group Inc. Sells 61,420 Shares of Merit Medical Systems, Inc. $MMSI

Vanguard Group Inc. trimmed its holdings in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 0.9% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 6,582,018 shares of the medical instruments supplier’s stock after selling 61,420 shares during the period. Vanguard Group Inc. owned approximately 0.11% of Merit Medical Systems worth $580,139,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Blue Trust Inc. lifted its holdings in shares of Merit Medical Systems by 11.0% during the 4th quarter. Blue Trust Inc. now owns 1,853 shares of the medical instruments supplier’s stock worth $163,000 after acquiring an additional 184 shares during the period. First Horizon Corp increased its position in shares of Merit Medical Systems by 19.7% during the 4th quarter. First Horizon Corp now owns 1,117 shares of the medical instruments supplier’s stock worth $98,000 after purchasing an additional 184 shares in the last quarter. CANADA LIFE ASSURANCE Co increased its position in shares of Merit Medical Systems by 0.4% during the 3rd quarter. CANADA LIFE ASSURANCE Co now owns 50,667 shares of the medical instruments supplier’s stock worth $4,095,000 after purchasing an additional 189 shares in the last quarter. Palouse Capital Management Inc. increased its position in shares of Merit Medical Systems by 27.5% during the 3rd quarter. Palouse Capital Management Inc. now owns 1,076 shares of the medical instruments supplier’s stock worth $90,000 after purchasing an additional 232 shares in the last quarter. Finally, CWM LLC increased its position in shares of Merit Medical Systems by 12.9% during the 3rd quarter. CWM LLC now owns 2,072 shares of the medical instruments supplier’s stock worth $172,000 after purchasing an additional 237 shares in the last quarter. 99.66% of the stock is owned by institutional investors.

Merit Medical Systems Price Performance

Shares of MMSI stock opened at $62.01 on Tuesday. Merit Medical Systems, Inc. has a 1 year low of $60.79 and a 1 year high of $100.19. The firm’s 50 day moving average is $70.68 and its 200-day moving average is $79.78. The firm has a market capitalization of $3.70 billion, a price-to-earnings ratio of 26.84, a PEG ratio of 1.75 and a beta of 0.58. The company has a current ratio of 5.08, a quick ratio of 3.46 and a debt-to-equity ratio of 0.45.

Merit Medical Systems (NASDAQ:MMSI) last announced its earnings results on Thursday, April 30th. The medical instruments supplier reported $0.94 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.84 by $0.10. Merit Medical Systems had a net margin of 9.03% and a return on equity of 13.54%. The company had revenue of $381.88 million for the quarter, compared to analyst estimates of $377.59 million. During the same period in the prior year, the business earned $0.86 earnings per share. Merit Medical Systems’s quarterly revenue was up 7.4% on a year-over-year basis. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. Sell-side analysts forecast that Merit Medical Systems, Inc. will post 3.61 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on MMSI. Needham & Company LLC dropped their target price on shares of Merit Medical Systems from $101.00 to $90.00 and set a “buy” rating for the company in a research report on Friday. Weiss Ratings reiterated a “hold (c)” rating on shares of Merit Medical Systems in a research report on Friday, March 27th. JPMorgan Chase & Co. dropped their target price on shares of Merit Medical Systems from $95.00 to $77.00 and set an “overweight” rating for the company in a research report on Friday. Canaccord Genuity Group dropped their target price on shares of Merit Medical Systems from $90.00 to $85.00 and set a “buy” rating for the company in a research report on Friday. Finally, Barrington Research dropped their target price on shares of Merit Medical Systems from $109.00 to $107.00 and set an “outperform” rating for the company in a research report on Monday, April 20th. Eight investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, Merit Medical Systems has a consensus rating of “Moderate Buy” and an average price target of $92.80.

Merit Medical Systems Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.